Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02862964 · ClinicalTrials.gov registry record
Accuro Versus Traditional Landmark Palpation Technique to Determine Accurate Spinal Level for Procedures
A clinical trial, sponsored by University of Virginia.
- Completed
- Registry status
- 106
- Enrollment target
NCT02862964: Completed study, sponsored by University of Virginia.
NCT02862964 is a clinical trial that has completed, run by University of Virginia. The registered enrollment target is 106 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02862964 has completed, sponsored by University of Virginia.
- COMPLETED
- Registry status
- 106 participants
- Enrollment target
Study Summary
Currently, at UVA, handheld ultrasound devices (like those used to view an unborn baby) are only two dimensional. The Accuro is a three dimensional handheld ultrasound device. This device uses sound waves to create pictures of the spine in three dimensions. This may allow the physician to view the spine in more detail for procedures such as spinal anesthesia and other diagnostic procedures. The investigators aim to assess the benefit of using the Accuro versus traditional landmark palpation technique to determine accurate spinal level for procedures. Patients who undergo interventional pain procedure per standard care under fluoroscopy and require the presence of an anesthesia provider at the UVA Pain Management Clinic will be approached for enrollment. Anesthesia Providers will first identify the L4/L5 space using the traditional technique of palpating the iliac crests to estimate spinal level, which will be marked with a single dot from a marking pen. The provider will then use the Accuro 3000 to identify the L4/L5 interspace and mark this point with two dots. Participants will then be taken into the fluoroscopy suite for their scheduled procedure. Since the skin marks will not show up on fluoroscopy, and metal instrument will be laid on the skin at the interspace or interspaces that were marked using the palpation and Accuro techniques. The anesthesiology attending provider in the fluoroscopy suite will then confirm the true interspace position of these marks under fluoroscopy. It will then be recorded how many spaces off the palpation and Accuro techniques are from the intended L4/L5 level.
Primary Outcome
whether there is a correlation between the landmark traditional technique versus US imaging. Fluoroscopy will serve a s the control (gold standard)
Interventions
- OTHER identify L4/L5
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 106 participants |
| Start Date | 2016-02 |
| Est. Completion | 2017-06-30 |
What the finished NCT02862964 record still lists
NCT02862964 is an observational study that tracks outcomes without assigning an intervention. The registered 106 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which identify L4/L5 is the first listed.
NCT02862964 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02862964 about?
NCT02862964 is a clinical study titled "Accuro Versus Traditional Landmark Palpation Technique to Determine Accurate Spinal Level for Procedures". Currently, at UVA, handheld ultrasound devices (like those used to view an unborn baby) are only two dimensional. The Accuro is a three dimensional handheld ultrasound device. This device uses sound waves to create pictures of the spine in three dimensions. This may allow the physician to view the s...
What is the current status of trial NCT02862964?
This trial is currently completed. The enrollment target is 106 participants. The study started on 2016-02. Estimated completion is 2017-06-30.
What interventions are being tested in trial NCT02862964?
The interventions under investigation include: identify L4/L5 (OTHER).
Who is sponsoring clinical trial NCT02862964?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03181048 · 106 participants · NA
Clinical Trial of Concomitant Hip Arthroscopy During PAO
- NCT04682158 · 106 participants · Phase 2
Propranolol With Standard Chemoradiation for Esophageal Adenocarcinoma
- NCT04724018 · 106 participants · Phase 1
Sacituzumab Govitecan Plus EV in Metastatic UC
- NCT04798274 · 106 participants · NA
Role of GABAergic Transmission in Auditory Processing in Autism Spectrum Disorder
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia